Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Anti-VEGF Therapy and Beyond: The Future of Retinal Disease Treatment
Link ID 25802
Title Anti-VEGF Therapy and Beyond: The Future of Retinal Disease Treatment
Url http://www.medscape.com/viewarticle/721962?src=rss
Description Anti-VEGF therapy is a significant breakthrough in the treatment of retinal disease; however, Dr. David Brown stresses the importance of continuing the search for future treatments in this video blog. Medscape Ophthalmology
Category Articles > Diabetes and Endocrinology
Keywords
Date Jun 3, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Diabetes and Endocrinology
1. Bisphosphonates Recommended for Patients Taking Glucocorticoids
  Revised guidelines on the prevention and treatment of osteoporosis related to glucocorticoid use recommend bisphosphonate therapy but withdraw endorsement of testosterone and estrogen for this purpose. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


2. A New Development: Sensor-Augmented Insulin-Pump Therapy
  A new device that combines an insulin pump with a continuous glucose monitoring system is evaluated for use in Type 1 diabetes. Journal Watch
Category:   Articles > Diabetes and Endocrinology


3. Both Amitriptyline and Duloxetine Ease Diabetic Neuropathy
  Pain associated with diabetic neuropathy is improved to a similar degree with daily amitriptyline or duloxetine, according to the results of a cross-over trial conducted in India. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


4. American Association of Clinical Endocrinologists (AACE) 17th Annual Meeting and Clinical Congress
  Read clinically focused news coverage of key developments from the meeting.
Category:   Articles > Diabetes and Endocrinology


5. Simvastatin Reduces Insulin Sensitivity in Patients With High Cholesterol
  Although simvastatin improves flow-mediated dilation in hypercholesterolemic patients, the drug reduces adiponectin levels and insulin sensitivity, according to a report in the April issue of Diabetes Care. These effects were not dose-dependent and also did not relate to the magnitude of apolipoprotein B reduction. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS